A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other CancerXu Xu, Albert Qin|Cancers|2024Cited by 1
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19Wang-Da Liu, Wang‐Huei Sheng, Weichung Joe Shih et al.|Infectious Diseases and Therapy|2024Cited by 0